SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001358403-20-000016
Filing Date
2020-05-07
Accepted
2020-05-07 16:56:39
Documents
62
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q blcm-20200331.htm   iXBRL 10-Q 1633095
2 EX-10.1 exh101-oxfordxsecondam.htm EX-10.1 127506
3 EX-31.1 exh3112020q1.htm EX-31.1 15653
4 EX-31.2 exh3122020q1.htm EX-31.2 16138
5 EX-32.1 exh3212020q1.htm EX-32.1 12313
  Complete submission text file 0001358403-20-000016.txt   6743873

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20200331.xsd EX-101.SCH 42500
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20200331_cal.xml EX-101.CAL 78167
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20200331_def.xml EX-101.DEF 223776
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20200331_lab.xml EX-101.LAB 544892
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20200331_pre.xml EX-101.PRE 366075
58 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20200331_htm.xml XML 1021128
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 20857368
SIC: 2834 Pharmaceutical Preparations